| EDD | effective drug duration; electron dense deposit; end-diastolic dimension; esophageal detection devic... |
|---|---|
| FDA | fluorescein diacetate; Food and Drug Administration; right frontoanterior [position of the fetus] |
| FD&C | Food, Drug and Cosmetic Act; food, drugs, and cosmetics |
| FDCPA | Food, Drug, and Consumer Product Agency |
| FDE | female day-equivalent; final drug evaluation |
| drug action |
The function of a drug in various body systems. Local: When the drug is applied locally or directly to a tissue or organ, it may combine with the cell's membrane or penetrate the cell. Its action may be (1) astringent when th
출처:
|
|---|---|
| drug administration |
Acids: When administered orally, acids should be given well diluted through a glass tube or by stomach tube because they are corrosive to the enamel and dentin of the teeth. They should be given with much water, and th
출처:
|
| drug antagonist |
A drug that prevents receptor stimulation. An antagonist drug has an affinity for a cell receptor and, by binding to it, prevents the cell from responding to an agonist.
출처:
|
| drug companion |
A medication whose efficacy depends on its use with a second agent. The same drug may have little effect when used alone.
출처:
|
| drug delivery, new methods of |
Several methods of drug delivery have been used experimentally. Included are chemical modification of a drug to enable it to penetrate membranes such as the blood-brain barrier; incorporation of microparticles in co
출처:
|